Fosamprenavir Calcium Salt - ≥95%, high purity , Human immunodeficiency virus type 1 protease inhibitor, CAS No.226700-81-8, Human immunodeficiency virus type 1 protease inhibitor

Item Number

F334964

Grouped product items
SKU	Size	Availability	Price
F334964-50mg	50mg	In stock	$171.90
F334964-100mg	100mg	In stock	$273.90
F334964-250mg	250mg	In stock	$464.90
F334964-1g	1g	Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!	$1,250.90

a water soluble protease inhibitor

Basic Description

Synonyms	Fosamprenavir calcium\|226700-81-8\|Fosamprenavir Calcium Salt\|Lexiva\|Telzir\|Amprenavir phosphate calcium\|Fosamprenavir (Calcium Salt)\|Fosamprenavir calcium [USAN]\|GW433908G\|UNII-ID1GU2627N\|GW 433908G\|GW-433908G\|ID1GU2627N\|DTXSID0046777\|DTXCID8026777\|((3S)O
Specifications & Purity	≥95%
Storage Temp	Store at -20°C
Shipped In	Ice chest + Ice pads
Action Type	INHIBITOR
Mechanism of action	Human immunodeficiency virus type 1 protease inhibitor
Product Description	Fosamprenavir Calcium Salt is a HIV protease inhibitor that is water soluble prodrug of amprenavir.

Names and Identifiers

IUPAC Name	calcium;[(2R,3S)-1-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-[[(3S)-oxolan-3-yl]oxycarbonylamino]-4-phenylbutan-2-yl] phosphate
INCHI	InChI=1S/C25H36N3O9PS.Ca/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21;/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32);/q;+2/p-2/t21-,23-,24+;/m0./s1
InChi Key	PMDQGYMGQKTCSX-HQROKSDRSA-L
Canonical SMILES	CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)C3=CC=C(C=C3)N.[Ca+2]
Isomeric SMILES	CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)C3=CC=C(C=C3)N.[Ca+2]
RTECS	EY8573300
PubChem CID	131535
Molecular Weight	623.67

Certificates

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

4 results found

Lot Number	Certificate Type	Date	Item
K2209603	Certificate of Analysis	Jun 30, 2022	F334964
K2209667	Certificate of Analysis	Jun 30, 2022	F334964
K2209668	Certificate of Analysis	Jun 30, 2022	F334964
K2209669	Certificate of Analysis	Jun 30, 2022	F334964

Solubility

Soluble in aqueous HCl, and DMF.

Sensitivity

Moisture sensitive.

Refractive Index

n20D1.61 (Predicted)

Melt Point(°C)

>257° C (dec.)

Safety and Hazards(GHS)

Pictogram(s)	GHS08, GHS07
Signal	Warning
Hazard Statements	H315:Causes skin irritation H351:Suspected of causing cancer H373:Causes damage to organs through prolonged or repeated exposure H361:Suspected of damaging fertility or the unborn child H362:May cause harm to breast-fed children
Precautionary Statements	P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P260:Do not breathe dust/fume/gas/mist/vapors/spray. P270:Do not eat, drink or smoke when using this product. P362+P364:Take off contaminated clothing and wash it before reuse. P263:Avoid contact during pregnancy/while nursing. P203:Obtain, read and follow all safety instructions before use. P318:if exposed or concerned, get medical advice. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell.
RTECS	EY8573300
RIDADR	NONHforallmodesoftransport

Solution Calculators

Determine the necessary mass, volume, or concentration for preparing a solution.

Determine the dilution needed to prepare a stock solution.

Basic Description